Literature DB >> 18327873

Nutritional calcium modulates colonic expression of vitamin D receptor and pregnane X receptor target genes.

Thomas Nittke1, Stephan Selig, Enikö Kallay, Heide S Cross.   

Abstract

Low nutritional calcium contributes to disruption of the intestinal epithelial barrier function, to hyperproliferation of colonocytes and increased occurrence of aggressive secondary bile acids in the gut lumen. These mechanisms are also known to be involved in the etiology of colonic inflammation and cancer. We studied in mice and human adenocarcinoma-derived Caco-2 cells the impact of low calcium on markers of inflammation (cyclooxygenase-2; COX-2), of detoxification (pregnane and xenobiotic receptor (PXR)/steroid and xenobiotic receptor (SXR), cytochrome P450 steroid-inducible 3a11 (CYP3A11)), and on expression of the vitamin D system as a protection against tumorigenesis. Caco-2 cells express high COX-2 and low SXR mRNA levels when subconfluent. During differentiation this is reversed, while low calcium enhanced COX-2 protein expression. In vivo low dietary calcium significantly increased the expression of the PXR target gene CYP3A11 in the proximal colon, suggesting compensatory defense mechanisms. In comparison with males, low nutritional calcium elicits a better protective response in females: both the vitamin D synthesizing 25-hydroxyvitamin D(3 )1alpha hydroxylase (CYP27B1) mRNA and the detoxifying CYP3A11 mRNA are augmented more. While it is recognized that colonic vitamin D synthesis may prevent tumor progression, low dietary calcium also elevates the 1,25-(OH)(2)-D(3) catabolic 25-hydroxyvitamin D(3) 24 hydroxylase (CYP24) expression primarily in the proximal colon. Our data suggest the proximal colon as the primary site of response to insufficient calcium intake.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18327873     DOI: 10.1002/mnfr.200700200

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  7 in total

1.  A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on markers of their metabolism in normal mucosa of colorectal adenoma patients.

Authors:  Thomas U Ahearn; Marjorie L McCullough; W Dana Flanders; Qi Long; Eduard Sidelnikov; Veronika Fedirko; Carrie R Daniel; Robin E Rutherford; Aasma Shaukat; Roberd M Bostick
Journal:  Cancer Res       Date:  2010-11-17       Impact factor: 12.701

2.  Role of bile acid secretion in human colorectal cancer.

Authors:  Meinrad Peterlik
Journal:  Wien Med Wochenschr       Date:  2008

3.  Expression profiling of colorectal cancer cells reveals inhibition of DNA replication licensing by extracellular calcium.

Authors:  Abhishek Aggarwal; Herbert Schulz; Teresa Manhardt; Martin Bilban; Rajesh V Thakker; Enikö Kallay
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-02-01       Impact factor: 4.739

4.  Indole-3-Propionic Acid, a Functional Metabolite of Clostridium sporogenes, Promotes Muscle Tissue Development and Reduces Muscle Cell Inflammation.

Authors:  Lei Du; Renli Qi; Jing Wang; Zuohua Liu; Zhenlong Wu
Journal:  Int J Mol Sci       Date:  2021-11-18       Impact factor: 5.923

Review 5.  Role of calcium, vitamin D, and the extrarenal vitamin D hydroxylases in carcinogenesis.

Authors:  Julia Höbaus; Ursula Thiem; Doris M Hummel; Enikö Kallay
Journal:  Anticancer Agents Med Chem       Date:  2013-01       Impact factor: 2.505

6.  Relative Expression of Vitamin D Hydroxylases, CYP27B1 and CYP24A1, and of Cyclooxygenase-2 and Heterogeneity of Human Colorectal Cancer in Relation to Age, Gender, Tumor Location, and Malignancy: Results from Factor and Cluster Analysis.

Authors:  Wolfgang Brozek; Teresa Manhardt; Enikö Kállay; Meinrad Peterlik; Heide S Cross
Journal:  Cancers (Basel)       Date:  2012-07-26       Impact factor: 6.639

Review 7.  PXR: a center of transcriptional regulation in cancer.

Authors:  Yaqi Xing; Jiong Yan; Yongdong Niu
Journal:  Acta Pharm Sin B       Date:  2019-06-29       Impact factor: 11.413

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.